BioMotiv is a developer of a drug development accelerator platform. The company is developing a portfolio of therapies based on technologies licensed from research institutions and industry sources. The company leverages a team and advisory board to select, fund and actively manage and advance a portfolio of progra BioMotiv was founded in 2012 and is headquartered in Cleveland, Ohio. The company seeks to expand its business portfolio through mergers and acquisitions.